Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences

This is the third in-person meeting of the consensus study, Assessing and Navigating Biosecurity Concerns and Benefits of Artificial Intelligence Use in the Life Sciences.

The open session of this information gathering meeting will include briefings containing information relevant to study issues. The committee will also meet in closed sessions to discuss the report.

The convergence of artificial intelligence (AI) and life sciences is an emerging area of research and development with promising benefits and applications but may also have security implications. This committee will consider the ways in which AI-enabled biological design tools and biological data sets for training AI can increase and mitigate biosecurity risks, specifically on concerns of transmissible biological threats that could pose significant epidemic and pandemic-scale consequences.

Highlighted agenda topics include:

• Understanding Pathogenesis of Transmissible Biological Agents and Impact of AI
• Opportunities to Use AI in Medical Countermeasures Development
• High Performance Computing in the Life Sciences

This meeting will be held over zoom. A recording of the open meeting will be available after it has ended.